The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for V Shanmugasundaram


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
14
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT2C) receptor agonists with exquisite functional selectivity over 5-HT2A and 5-HT2B receptors.EBI
Pfizer
8
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria.EBI
Pfizer
27
Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.EBI
Pfizer
1
Potent inhibitors of LpxC for the treatment of Gram-negative infections.EBI
Pfizer
40
Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.EBI
Pfizer
13
Smoothened antagonists for hair inhibition.EBI
Pfizer
5
Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.EBI
Pfizer
24
Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment.EBI
Emory University
17
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2).EBI
Bristol Myers Squibb
50
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.EBI
Pfizer
1
Inducing protein-protein interactions with molecular glues.EBI
Pfizer
16
Small-molecule HSP90 inhibitorsBDB
Memorial Sloan-Kettering Cancer Center